Biorestorative Therapies Inc (BRTX)

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Biorestorative Therapies Inc Stock (BRTX) Company Profile

Biorestorative Therapies Inc

(631) 760-8100

40 MARCUS DRIVE, MELVILLE

Prossima data di guadagno

Ultimi documenti SEC

BRTX's Discussions on Twitter

Biorestorative Therapies Inc Borsa (BRTX) Ultime notizie

Biorestorative Therapies Inc Azioni (BRTX) Dati Finanziari

Biorestorative Therapies Inc Azioni (BRTX) insider trading

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Silva Francisco	VP of Research and Development	Apr 08 '24	Buy	1.16	1,708	1,979	149,159
Broadrick Dale	10% Owner	Feb 09 '24	Buy	1.32	86,041	113,574	477,972
Broadrick Dale	10% Owner	Feb 08 '24	Buy	1.25	73,959	92,449	391,931
Broadrick Dale	10% Owner	Feb 08 '24	Buy	1.34	83,626	112,059	447,045
Broadrick Dale	10% Owner	Feb 07 '24	Buy	1.38	36,374	50,196	363,419
Broadrick Dale	10% Owner	Dec 01 '23	Sale	1.88	250	469	327,045
Broadrick Dale	10% Owner	Nov 27 '23	Sale	1.89	278	525	327,295

Biorestorative Therapies Inc (BRTX)

Biorestorative Therapies Inc Stock (BRTX) Company Profile

Biorestorative Therapies Inc Borsa (BRTX) Ultime notizie

BioRestorative Therapies (OTCMKTS:BRTXQ) Hits New 1-Year High at $1.50 - MarketBeat

BioRestorative Therapies (OTCMKTS:BRTX) Stock Passes Below 50-Day Moving Average of $1.65 - Defense World

BioRestorative Therapies (NASDAQ:BRTX) Shares Up 1.3% - Defense World

BioRestorative Therapies (OTCMKTS:BRTXQ) Hits New 12-Month High at $1.64 - MarketBeat

BioRestorative Therapies, Inc. (NASDAQ:BRTX) Sees Large Decline in Short Interest - Defense World

BioRestorative Therapies (OTCMKTS:BRTX) Shares Pass Below 50-Day Moving Average of $1.69 - Defense World

BioRestorative Therapies (OTCMKTS:BRTXQ) Sets New 12-Month High at $1.75 - MarketBeat

BioRestorative Therapies, Inc. announced that it has received $0.5 million in funding - Marketscreener.com

BioRestorative Therapies (OTCMKTS:BRTX) Share Price Crosses Below 50 Day Moving Average of $1.70 - Defense World

BioRestorative Therapies, Inc. (NASDAQ:BRTX) Forecasted to Earn Q3 2024 Earnings of ($0.36) Per Share - Defense World

BioRestorative Therapies (NASDAQ:BRTX) PT Raised to $18.00 at Roth Mkm - Defense World

BioRestorative Therapies, Inc. (NASDAQ:BRTX) Q2 2024 Earnings Call Transcript - Insider Monkey

BioRestorative Therapies (NASDAQ:BRTX) Releases Earnings Results, Beats Expectations By $0.06 EPS - Defense World

Roth Capital Equities Analysts Reduce Earnings Estimates for BioRestorative Therapies, Inc. (NASDAQ:BRTX) - Defense World

Roth/MKM raises BioRestorative Therapies stock target on Phase 2 clinical trial - Investing.com India

Roth/MKM raises BioRestorative Therapies stock target on Phase 2 clinical trial - Investing.com

BRTX Stock Earnings: BioRestorative Therapies Beats EPS, Beats Revenue for Q2 2024 - InvestorPlace

BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update - OrthoSpineNews

Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update - StockTitan

BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update - ForexTV.com

BioRestorative Therapies, Inc. (NASDAQ:BRTX) Short Interest Update - Defense World

Head-To-Head Review: BioRestorative Therapies (OTCMKTS:BRTX) vs. Arno Therapeutics (OTCMKTS:ARNI) - Defense World

BioRestorative Therapies (BRTX) to Release Quarterly Earnings on Tuesday - Defense World

BioRestorative Therapies to Report Second Quarter 2024 - GlobeNewswire

BioRestorative Therapies to Report Second Quarter 2024 Financial Results and Host Conference Call on August 13, 2024 - Yahoo Finance

BioRestorative Therapies (OTCMKTS:BRTX) Stock Passes Below 50-Day Moving Average of $1.66 - Defense World

BioRestorative Therapies’ Chief Scientist Named New Section - GlobeNewswire

BioRestorative Therapies’ Chief Scientist Named New Section Editor of the Prestigious Journal of Translational Medicine - StockTitan

BioRestorative Therapies, Inc. (NASDAQ:BRTX) Sees Significant Decline in Short Interest - Defense World

Taking a look at what insiders are doing to gauge the BioRestorative Therapies Inc (BRTX)'s direction – Knox Daily - Knox Daily

Technical analysis of BioRestorative Therapies Inc (BRTX) stock chart patterns – US Post News - US Post News

Analyzing Ratios: BioRestorative Therapies Inc (BRTX)'s Financial Story Unveiled – DWinneX - The Dwinnex

BioRestorative Therapies maintains $15 target on Japan patent news - Investing.com

BioRestorative Therapies maintains $15 target on Japan patent news By Investing.com - Investing.com UK

BioRestorative Therapies Announces Notice of Allowance for - GlobeNewswire

BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem ... - StockTitan

BioRestorative Therapies (OTCMKTS:BRTXQ) Sets New 52-Week High at $2.20 - Defense World

BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program - Yahoo Finance

Investing in BioRestorative Therapies Inc (BRTX): What You Must Know – Knox Daily - Knox Daily

Bullish BioRestorative Therapies, Inc. (NASDAQ:BRTX) insiders filled their treasuries with US$593k worth of stock over ... - Yahoo New Zealand News

Check out these key findings about BioRestorative Therapies Inc (BRTX) – Sete News - SETE News

Market Recap Check: BioRestorative Therapies Inc (BRTX)'s Negative Finish at 2.03, Up/Down -8.56 – DWinneX - The Dwinnex

The Attractiveness of Investing In BioRestorative Therapies Inc (BRTX) is Growing – Knox Daily - Knox Daily

Promising Developments in Waldenstrom Macroglobulinemia Treatment: Mustang Bio's Latest Clinical Trial Results ... - BP Journal

BioRestorative Therapies regains compliance, reports Q1 2024 results - MSN

What's Going On With BioRestorative Therapies Stock? - MSN

BRTXBioRestorative Therapies, Inc. Latest Stock News & Market Updates - StockTitan

What's Going On With BioRestorative Therapies Stock?BioRestorative Therapies (NASDAQ:BRTX) - Benzinga

Q2 2024 EPS Estimates for BioRestorative Therapies, Inc. (NASDAQ:BRTX) Cut by Analyst - Defense World

Biorestorative Therapies Inc Azioni (BRTX) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Biorestorative Therapies Inc Azioni (BRTX) insider trading

Simile a BRTX